Michelle McMurry-Heath | |
|---|---|
 McMurry-Heath in 2020 | |
| Education | Harvard University (BS) Duke University (MD, PhD) |
| Scientific career | |
| Fields | Health policy |
| Institutions | Biotechnology Innovation Organization, Johnson & Johnson, Food and Drug Administration |
Michelle McMurry-Heath is a medical doctor, immunologist, and from June 2020 until October 2022 served as chief executive officer for the Biotechnology Innovation Organization (BIO).
McMurry-Heath was born and raised in Oakland, California. [1] Her mother was a public health nurse, and her father was a psychologist. [1]
After first pursuing a double major in art history and psychology during college, she changed her focus to biochemistry and received an undergraduate degree from Harvard University in biochemistry. [1] She is the first Black graduate of the Duke University combined MD / Ph.D. Medical Scientist Training Program, and completed her Ph.D. in immunology. [1] [2]
After completing her education, McMurry-Heath worked in research for 12 years. [3] After training from the Robert Wood Johnson Foundation, she shifted to science policy, which included work from 2001 to 2004 as a legislative aide for Senator Joe Lieberman and drafting a bioterrorism preparedness bill in 2002. [1] [3] [4]
During her work with the Aspen Institute, she was a founding director of the Aspen Institute's Health, Biomedical Science, and Society Policy Program. [4] She also worked as an adjunct assistant professor of health policy at George Washington University. [4] In 2010, she became the associate director at the Center for Devices and Radiological Health at the Food and Drug Administration. [1] In this role, she developed partnerships with medical device nonprofits. [5]
Towards the end of 2014, she became an executive at Johnson & Johnson and her management role later expanded. [1] [6] While at Johnson & Johnson, she was advised by Michael D. Watkins, who continued as an advisor after she moved to her role as president and CEO of the Biotechnology Innovation Organization (BIO). [1]
She has previously worked with the Council on Foreign Relations. [7] From 2018 to 2020, she was Chair of the NESTcc Governing Committee. [8] She is a member of the AAAS Committee on Science, Engineering and Public Policy (COSEPP). [9]
In June 2020, McMurry-Heath became the chief executive of the Biotechnology Innovation Organization (BIO), a lobbying organization that represents several hundred biotech companies, [1] [10] [11] including most of the companies that developed COVID-19 vaccines, [12] as well as academic institutions. [13] At BIO, she led the Coronavirus Collaboration Initiative, a group focused on developing COVID-19 vaccines and treatments. [14] In 2021, she was named as a possible nominee to lead the Food and Drug Administration. [15] [16] [17]
McMurry-Heath resigned from her role as CEO of BIO effective October 11, 2022, and she continues to serve as an advisor to the board. [18] [19]
McMurry-Heath is married to Sebastian Heath, a veterinarian. They have one daughter and currently live in Washington, D.C. [7]
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Patrick Soon-Shiong is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.
Michelle Dipp is an American scientist, businesswoman, and investor. She is the co-founder and a managing partner at Biospring Partners and serves on the board of Abzena and Kiniciti.
Brett P. Giroir is an American pediatrician. He was formerly the U.S. assistant secretary for health, a four-star admiral in the U.S. Public Health Service Commissioned Corps and an acting Food and Drug Administration commissioner.
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
Sara Radcliffe is an American medical research advocate and business executive. She is the president and CEO of California Life Sciences Association, a non-profit organization that advocates for the medical research mission of the life sciences sector of California. She is best known for her expertise in the field of applied public health and an advocate for life sciences.
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), and changed its name to the Biotechnology Innovation Organization on January 4, 2016. Biotechnology Innovation Organization serves more than 1,100 biotechnology firms, research schools, state biotechnology centers and related associations in the United States and in more than 30 other countries.
Eve Elizabeth Slater is an American physician who served as the United States Assistant Secretary for Health and Human Services under President George W. Bush from 2002 to 2003. Slater received her B.A from Vassar College in 1967 and M.D. from the Columbia University College of Physicians and Surgeons in 1971. She completed residency in internal medicine and fellowship in cardiology at the Massachusetts General Hospital, Boston, MA.In 1976, she was appointed the Chief Resident in Medicine at Massachusetts General Hospital, the first woman to appointed to this position. Dr. Slater is currently Professor of Clinical Medicine at Columbia Vagelos College of Physicians and Surgeons (P&S), where she has taught for over 35 years. She is board certified in internal medicine and cardiology and a fellow of the American College of Cardiology.(FACC). At MGH, she led the Hypertension Unit, as Assistant Professor of Medicine. Harvard Medical School.
Janet Woodcock is an American physician who served as Principal Deputy Commissioner of Food and Drugs from February 2022 until February 2024, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA). She joined the FDA in 1986, and has held a number of senior leadership positions there, including terms as the Director of Center for Drug Evaluation and Research (CDER) from 1994 to 2004 and 2007 to 2021.
Shenzhen International BT Leadership Summit is a biology-focused business conference. It is held each year in September. It is arranged by the Shenzhen Municipal People's Government. It is held at the Shenzhen Convention and Exhibition Center.
The Bill & Melinda Gates Medical Research Institute is a non-profit biotechnology organization founded with the aim of bringing technologies and strategies to bear on the main health problems of the poor in low-income countries. The Gates MRI was organized as a subsidiary of the Bill & Melinda Gates Foundation who funded it with a $273 million 4-year grant.
Richard Hatchett is an American oncologist and epidemiologist who has been serving as chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI) in Oslo and London since 2017. He was awarded the Secretary of Health and Human Services's Award for Distinguished Service.
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.
Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.
Albert Bourla is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer.
Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.
{{cite book}}: |author2= has generic name (help)